{
    "root": "35a85fd5-5a85-78c7-e063-6294a90ab203",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "aripiprazole",
    "value": "20250521",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78"
        }
    ],
    "indications": "aripiprazole tablets atypical antipsychotic . aripiprazole tablets indicated : schizophrenia ( 14.1 ) acute treatment manic mixed episodes associated bipolar disorder ( 14.2 ) adjunctive treatment major depressive disorder ( 14.3 ) irritability associated autistic disorder ( 14.4 ) treatment tourette 's disorder ( 14.5 )",
    "contraindications": "administer daily without regard meals ( 2 ) initial dose recommended dose maximum dose schizophrenia – adults ( 2.1 ) 10 15 mg/day 10 15 mg/day 30 mg/day schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day bipolar mania – adults : monotherapy ( 2.2 ) 15 mg/day 15 mg/day 30 mg/day bipolar mania – adults : adjunct lithium valproate ( 2.2 ) 10 15 mg/day 15 mg/day 30 mg/day bipolar mania – pediatric patients : monotherapy adjunct lithium valproate ( 2.2 ) 2 mg/day 10 mg/day 30 mg/day major depressive disorder – adults : adjunct antidepressants ( 2.3 ) 2 5 mg/day 5 10 mg/day 15 mg/day irritability associated autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15 mg/day tourette 's disorder – ( 2.5 ) patients ˂ 50 kg 2 mg/day 5 mg/day 10 mg/day patients ≥ 50 kg 2 mg/day 10 mg/day 20 mg/day known cyp2d6 poor metabolizers : half usual dose ( 2 . 6 )",
    "warningsAndPrecautions": "aripiprazole tablets , usp 20 mg white off-white , round , uncoated tablets , debossed `` 20 `` sides . ndc 60760-691-30 bottles 30",
    "adverseReactions": "known hypersensitivity aripiprazole ( 4 )",
    "indications_original": "Aripiprazole tablets are an atypical antipsychotic. Aripiprazole tablets are indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Adjunctive Treatment of Major Depressive Disorder ( 14.3 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's Disorder ( 14.5 )",
    "contraindications_original": "Administer once daily without regard to meals ( 2 ) Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Bipolar mania – adults: monotherapy ( 2.2 ) 15 mg/day 15 mg/day 30 mg/day Bipolar mania – adults: adjunct to lithium or valproate ( 2.2 ) 10 to 15 mg/day 15 mg/day 30 mg/day Bipolar mania – pediatric patients: monotherapy or as an adjunct to lithium or valproate ( 2.2 ) 2 mg/day 10 mg/day 30 mg/day Major Depressive Disorder – adults: adjunct to antidepressants ( 2.3 ) 2 to 5 mg/day 5 to 10 mg/day 15 mg/day Irritability associated with autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette's Disorder – ( 2.5 ) Patients ˂ 50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥ 50 kg 2 mg/day 10 mg/day 20 mg/day Known CYP2D6 poor metabolizers: Half of the usual dose ( 2. 6)",
    "warningsAndPrecautions_original": "Aripiprazole tablets, USP 20 mg are white to off-white, round, uncoated tablets, debossed with \"20\" on both sides.\n                  \n                  NDC 60760-691-30 BOTTLES OF 30",
    "adverseReactions_original": "Known hypersensitivity to aripiprazole ( 4 )"
}